History

Venture Valuation was founded in spring 1999 based on research work by the founder and CEO, Dr. Patrik Frei, at the University of St. Gallen (HSG) and the Swiss Federal Institute of Technology in Lausanne (EPFL). Since the very beginning, Novartis Venture Fund (part of the worldwide life science company Novartis International AG) was a main customer for which Venture Valuation carries out all external valuations. After two years in Lucern, Switzerland, the company moved to Zurich for the purpose of expansion. At the same time, Venture Valuation opened additional offices in London, Canada as well as in Munich, Germany. In 2003 the Life Sciences Database Biotechgate was added and has been expanded to 3 continents. In 2005 Venture Valuation stated a collaboration with EBD Group to provide the software for their Partnering system "PartneringOne".

In 2009 Venture Valuation celebrated the company's 10 year anniversary. We would like to say thank you to all our clients, cooperation partners and employees which supported us in the past years.